The federal appeals court also warned against ‘overreading’ its ruling and said a rapid appeal process could result in a ‘more tailored and appropriate’ order.
Texas sued the companies in 2023, alleging they provided adulterated Quillivant XR to children on Medicaid despite manufacturing and quality control issues.
A federal appeals court previously ruled that an asylum seeker stopped on the Mexican side of the border should be considered to have arrived in the U.S.